Ex Parte Falta et al - Page 4

           Appeal 2006-1708                                                                         
           Application 10/186,253                                                                   

        1        In evaluating prior art references, it is proper to take into account not only     
        2  the specific teachings of the references but also the inferences which one skilled in    
        3  the art would reasonably be expected to draw therefrom.  In re Preda, 401 F.2d           
        4  825, 826, 159 USPQ 342, 344 (CCPA 1968).                                                 
        5        The reason or motivation to modify the reference may often suggest what            
        6  the inventor has done, but for a different purpose or to solve a different problem.  It  
        7  is not necessary that the prior art suggest the combination to achieve the same          
        8  advantage or result discovered by applicant.  See In re Kahn, 441 F.3d 977, 987, 78      
        9  USPQ2d 1329, 1336 (Fed. Cir. 2006) (motivation question arises in the context of         
       10  the general problem confronting the inventor rather than the specific problem            
       11  solved by the invention).                                                                
       12        Any need or problem known in the field of endeavor at the time of the              
       13  invention and addressed by the prior art can provide a reason for combining              
       14  elements in the manner claimed.  KSR Int’l, 127 S.Ct. at 1742, 82 USPQ2d at              
       15  1397.                                                                                    
       16        An appellant who is asserting unexpected results to support a contention of        
       17  nonobviousness bears the burden of proof of establishing the results are                 
       18  unexpected.  See In re Klosak, 455 F.2d 1077, 1080, 173 USPQ 14, 16 (CCPA                
       19  1972) and In re Freeman 474 F.2d 1318, 1324, 177 USPQ 139, 143 (CCPA 1973).              
       20  When unexpected results are used as evidence of nonobviousness, the results must         
       21  be shown to be unexpected as compared with the closest prior art.  In re Baxter          
       22  Travenol Labs., 952 F.2d 388, 392, 21 USPQ2d 1281, 1285 (Fed. Cir. 1991), citing         
       23  In re De Blauwe, 736 F.2d 699, 705, 222 USPQ 191, 196 (Fed. Cir. 1984).                  
       24        An appellant who is asserting commercial success to support a contention of        
       25  nonobviousness bears the burden of proof of establishing a nexus between the             
       26  claimed invention and evidence of commercial success.                                    

                                                 4                                                  


Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next

Last modified: September 9, 2013